ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
2
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,643
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Reversal of dabigatran with idarucizumab in hyperacute stroke: a new paradigm?
Author(s):
Amy Ting
1
,
Abhay R Venkat
1
,
2
,
Yash Gawarikar
2
,
3
,
Ronak Patel
2
,
3
Publication date
(Electronic):
April 2019
Journal:
The Medical journal of Australia
Publisher:
Wiley
Keywords:
Anticoagulants
,
Carotid artery
,
Novel oral anticoagulants (NOACs)
,
Stroke
,
Thrombolysis
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Stroke MRI
Author and article information
Journal
Journal ID (iso-abbrev):
Med J Aust
Title:
The Medical journal of Australia
Publisher:
Wiley
ISSN (Electronic):
1326-5377
ISSN (Print):
0025-729X
Publication date (Electronic):
April 2019
Volume
: 210
Issue
: 7
Affiliations
[
1
]
Canberra Hospital, Canberra, ACT.
[
2
]
Calvary Public Hospital Bruce, Canberra, ACT.
[
3
]
Australian National University, Canberra, ACT.
Article
DOI:
10.5694/mja2.50122
PubMed ID:
30924530
SO-VID:
98035876-b859-42f8-92a7-5ab5d0382d24
History
Keywords:
Anticoagulants
,
Carotid artery
,
Novel oral anticoagulants (NOACs)
,
Stroke
,
Thrombolysis
Data availability:
Keywords:
Anticoagulants
,
Carotid artery
,
Novel oral anticoagulants (NOACs)
,
Stroke
,
Thrombolysis
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,643
Effect of dabigatran on the ability to generate fibrin at a wound site and its reversal by idarucizumab, the antidote to dabigatran
Authors:
J. Van Ryn
,
M. Schmoll
,
H. Pillu
Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model
Authors:
M Honickel
,
T Braunschweig
,
J Ryn
…
262 Initial Experience With Idarucizumab in Dabigatran-Treated Patients Presenting With Acute Traumatic Injuries: Interim Results From the RE-VERSE AD Study
Authors:
C.V. Pollack
,
F. Gruenenfelder
,
J. Eikelboom
…
See all similar
Cited by
2
Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature
Authors:
Senta Frol
,
Dimitrios Sagris
,
Janja Pretnar Oblak
…
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
Authors:
David Giannandrea
,
Anna Mengoni
,
Erberto Carluccio
…
See all cited by